Skip to main content
Journal of Ovarian Research logoLink to Journal of Ovarian Research
. 2024 May 24;17:112. doi: 10.1186/s13048-024-01438-9

Correction: A methylation‑ and immune‑related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance

Lu Chen 1,2,#, Wujiang Gao 1,3,#, Li Lin 1,#, Chunli Sha 1,4, Taoqiong Li 1, Qi Chen 1, Hong Wei 1, Meiling Yang 1,4, Jie Xing 1, Mengxue Zhang 1, Shijie Zhao 1, Wenlin Xu 1,✉, Yuefeng Li 5,✉, Lulu Long 6,✉, Xiaolan Zhu 1,✉
PMCID: PMC11127421  PMID: 38790048

Correction: J Ovarian Res 16, 186 (2023)

10.1186/s13048-023-01260-9

Following publication of the original article [1], an error was spotted in Fig. 4a where the x-axis should say ‘time (months)’ rather than ‘time (mouths)’. The correct images were shown below.

Incorrect figure:graphic file with name 13048_2024_1438_Figa_HTML.jpg

Correct figure:graphic file with name 13048_2024_1438_Figb_HTML.jpg

The original article has been corrected.

Footnotes

Lu Chen, Wujiang Gao and Li Lin are equal contributors.

Contributor Information

Wenlin Xu, Email: 1585896219@qq.com.

Yuefeng Li, Email: jiangdalyf@163.com.

Lulu Long, Email: 2221913106@stmail.ujs.edu.cn.

Xiaolan Zhu, Email: 6000003983@ujs.edu.cn.

Reference

  • 1.Chen L, Gao W, Lin L, et al. A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance. J Ovarian Res. 2023;16:186. doi: 10.1186/s13048-023-01260-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Ovarian Research are provided here courtesy of BMC

RESOURCES